Next Article in Journal
Pharmacognostic and Antioxidant Properties of Dracaena sanderiana Leaves
Next Article in Special Issue
Tart Cherry Extracts Reduce Inflammatory and Oxidative Stress Signaling in Microglial Cells
Previous Article in Journal
Antioxidant Properties of Water-Soluble Gum from Flaxseed Hulls
Previous Article in Special Issue
Berry Leaves: An Alternative Source of Bioactive Natural Products of Nutritional and Medicinal Value
Open AccessReview

Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents

1
Department of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA
2
Department of Food Science and Technology, University of Nebraska, 256 Food Innovation Complex, Lincoln, NE 68588-6205, USA
3
Department of Statistics, University of Nebraska, Lincoln, NE 68583, USA
4
Quantitative Life Sciences Initiative, University of Nebraska, Lincoln, NE 68583, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Dorothy Klimis-Zacas
Antioxidants 2016, 5(3), 27; https://doi.org/10.3390/antiox5030027
Received: 30 June 2016 / Revised: 11 August 2016 / Accepted: 15 August 2016 / Published: 18 August 2016
(This article belongs to the Special Issue Berry Antioxidants in Health and Disease)
Cranberries are rich in bioactive constituents reported to influence a variety of health benefits, ranging from improved immune function and decreased infections to reduced cardiovascular disease and more recently cancer inhibition. A review of cranberry research targeting cancer revealed positive effects of cranberries or cranberry derived constituents against 17 different cancers utilizing a variety of in vitro techniques, whereas in vivo studies supported the inhibitory action of cranberries toward cancers of the esophagus, stomach, colon, bladder, prostate, glioblastoma and lymphoma. Mechanisms of cranberry-linked cancer inhibition include cellular death induction via apoptosis, necrosis and autophagy; reduction of cellular proliferation; alterations in reactive oxygen species; and modification of cytokine and signal transduction pathways. Given the emerging positive preclinical effects of cranberries, future clinical directions targeting cancer or premalignancy in high risk cohorts should be considered. View Full-Text
Keywords: cranberry; cancer; proanthocyanidin; quercetin; ursolic acid cranberry; cancer; proanthocyanidin; quercetin; ursolic acid
Show Figures

Graphical abstract

MDPI and ACS Style

Weh, K.M.; Clarke, J.; Kresty, L.A. Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents. Antioxidants 2016, 5, 27.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop